Sahakyan, Yeva, et al. “Cost-Utility of Minimally Invasive Therapies Vs. Pharmacotherapy As Initial Therapy for Benign Prostatic Hyperplasia: A Canadian Healthcare Payer Perspective”. Canadian Urological Association Journal, vol. 17, no. 4, Dec. 2022, pp. 103-10, doi:10.5489/cuaj.8045.